Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the treatment of BRD in cattle, and the control of respiratory disease in cattle at high risk of developing BRD.
LEARN MOREFor the vaccination of healthy pregnant swine to provide passive immunity against rotaviral diarrhea, colibacillosis and enterotoxemia due to…
LEARN MOREFor vaccination of healthy chickens 6-18 weeks of age by wing-web administration in the prevention of fowl pox.
LEARN MOREAn aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by Salmonella Choleraesuis and as an aid in control of disease caused by…
LEARN MORE